Abstract
Background: Zolmitriptan is the drug of choice for the treatment of migraine with or without aura. Oral bioavailability of drug is 40% due to high first pass metabolism. Elimination half life is 3 hrs and drug degradation occurs in acidic environment of GIT.
Objective: The objective was to prepare intestinal targeted delivery for Zolmitriptan which will release the drug by pulsatile effect in small intestine by retarding drug release in upper GI tract.
Method: Targeted delivery was prepared by compression coating technique. 32 factorial design was applied with independent variables polyoxN12K and methacrylic acid. Core tablet consists of croscarmellose sodium as superdisintegrant, avicel as binder, dicalcium phosphate as diluent and zolmitriptan as drug. Outer coating of polyoxN12K and methacrylic acid was applied in compression coating.
Results: Optimized batch F8 consist of polyoxN12K (60%) & methacrylic acid (3%). In-vitro release study in simulated media indicated presence of the tablet in small intestine giving burst release. In-vivo placebo X- ray radiographic technique for F8 showed that tablet was not adhered throughout GIT and bypass stomach.
Conclusion: Study indicated F8 can be a potential to achieve the targeted site delivery for zolmitriptan.
Keywords: Chronobiology, drug delivery, lag time, migraine, pulsatile, zolmitriptan.
Current Drug Therapy
Title:Optimization of Site Targeted Zolmitriptan Delivery Using Polyox N12K and Methacrylic Acid
Volume: 11 Issue: 1
Author(s): Swati C. Jagdale and Suchita G. Nagalgawe
Affiliation:
Keywords: Chronobiology, drug delivery, lag time, migraine, pulsatile, zolmitriptan.
Abstract: Background: Zolmitriptan is the drug of choice for the treatment of migraine with or without aura. Oral bioavailability of drug is 40% due to high first pass metabolism. Elimination half life is 3 hrs and drug degradation occurs in acidic environment of GIT.
Objective: The objective was to prepare intestinal targeted delivery for Zolmitriptan which will release the drug by pulsatile effect in small intestine by retarding drug release in upper GI tract.
Method: Targeted delivery was prepared by compression coating technique. 32 factorial design was applied with independent variables polyoxN12K and methacrylic acid. Core tablet consists of croscarmellose sodium as superdisintegrant, avicel as binder, dicalcium phosphate as diluent and zolmitriptan as drug. Outer coating of polyoxN12K and methacrylic acid was applied in compression coating.
Results: Optimized batch F8 consist of polyoxN12K (60%) & methacrylic acid (3%). In-vitro release study in simulated media indicated presence of the tablet in small intestine giving burst release. In-vivo placebo X- ray radiographic technique for F8 showed that tablet was not adhered throughout GIT and bypass stomach.
Conclusion: Study indicated F8 can be a potential to achieve the targeted site delivery for zolmitriptan.
Export Options
About this article
Cite this article as:
C. Jagdale Swati and G. Nagalgawe Suchita, Optimization of Site Targeted Zolmitriptan Delivery Using Polyox N12K and Methacrylic Acid, Current Drug Therapy 2016; 11 (1) . https://dx.doi.org/10.2174/1574885511666160421145754
DOI https://dx.doi.org/10.2174/1574885511666160421145754 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Immunosuppressive Therapies in Solid Organ Transplantation
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Antimuscarinics in the Treatment of OAB: Is there a First-Line and a Second-Line Choice?
Current Drug Targets Ketamine Treatment in Depression: A Systematic Review of Clinical Characteristics Predicting Symptom Improvement
Current Topics in Medicinal Chemistry Computational Approach to Combat COVID-19 Infection: Emerging Tools for Accelerating Drug Research
Current Drug Discovery Technologies Pharmacotherapy in Systemic Lupus Erythematosus
Current Rheumatology Reviews Preconception Counselling: A Five- Year Experience in a Teratology Information Service
Letters in Drug Design & Discovery Duloxetine in the Treatment of Depression: An Overview
Central Nervous System Agents in Medicinal Chemistry Systemic Adverse Drug Reactions Secondary to Anti-VEGF Intravitreal Injection in Patients with Neovascular Age-Related Macular Degeneration
Current Vascular Pharmacology Limitations of Current Antiretroviral Agents and Opportunities for Development
Current Pharmaceutical Design Development of Anti-Viral Agents Using Molecular Modeling and Virtual Screening Techniques
Infectious Disorders - Drug Targets Post-COVID-19 Syndrome Clinical Manifestations: A Systematic Review
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Patient Perspectives in OMERACT Provide an Anchor for Future Metric Development and Improved Approaches to Healthcare Delivery in Connective Tissue Disease Related Interstitial Lung Disease (CTD-ILD)
Current Respiratory Medicine Reviews Monoamine Oxidase B Inhibitors in Parkinson's Disease
CNS & Neurological Disorders - Drug Targets Depression and Treatment with Effective Herbs
Current Pharmaceutical Design Disulfiram: An Old Therapeutic with New Applications
CNS & Neurological Disorders - Drug Targets The Therapeutic Potential of Melatonin in Neurological Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Treatment Outcome of Three Female Adolescents with Borderline Personality Disorder
Adolescent Psychiatry Arterial Ischemic Stroke in Neonates and Children: Review and Current Issues
Current Pediatric Reviews The Effects of Psychological Stress on Depression
Current Neuropharmacology Recent Updates on Biological Activities of Oxadiazoles
Mini-Reviews in Medicinal Chemistry